XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 61 filers reported holding XBIOTECH INC in Q1 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $270,000 | -22.2% | 31,300 | +0.3% | 0.00% | – |
Q4 2021 | $347,000 | -14.1% | 31,200 | 0.0% | 0.00% | – |
Q3 2021 | $404,000 | -21.9% | 31,200 | 0.0% | 0.00% | – |
Q2 2021 | $517,000 | +2.4% | 31,200 | +6.1% | 0.00% | – |
Q1 2021 | $505,000 | -0.8% | 29,400 | -9.5% | 0.00% | – |
Q4 2020 | $509,000 | -22.5% | 32,500 | -5.5% | 0.00% | – |
Q3 2020 | $657,000 | +39.2% | 34,400 | 0.0% | 0.00% | – |
Q2 2020 | $472,000 | +29.3% | 34,400 | 0.0% | 0.00% | – |
Q1 2020 | $365,000 | +27.6% | 34,400 | +124.8% | 0.00% | – |
Q4 2019 | $286,000 | +100.0% | 15,300 | +11.7% | 0.00% | – |
Q3 2019 | $143,000 | -37.3% | 13,700 | -67.9% | 0.00% | – |
Q1 2018 | $228,000 | +35.7% | 42,700 | 0.0% | 0.00% | – |
Q4 2017 | $168,000 | -8.2% | 42,700 | +2.2% | 0.00% | – |
Q3 2017 | $183,000 | -9.0% | 41,800 | -2.3% | 0.00% | – |
Q2 2017 | $201,000 | -34.5% | 42,800 | +130.1% | 0.00% | – |
Q1 2017 | $307,000 | +63.3% | 18,600 | 0.0% | 0.00% | – |
Q4 2016 | $188,000 | -24.8% | 18,600 | 0.0% | 0.00% | – |
Q3 2016 | $250,000 | -30.9% | 18,600 | +7.5% | 0.00% | – |
Q2 2016 | $362,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Oasis Management Co Ltd. | 137,174 | $497,000 | 0.08% |
LGT Fund Management Co Ltd. | 10,000 | $36,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,000 | $481,000 | 0.01% |
RBF Capital, LLC | 23,172 | $84,000 | 0.01% |
Thomasville National Bank | 13,350 | $48,000 | 0.01% |
Trexquant Investment LP | 21,975 | $80,000 | 0.00% |
Connor, Clark & Lunn Investment Management Ltd. | 67,975 | $246,000 | 0.00% |
HRT FINANCIAL LP | 40,987 | $148,000 | 0.00% |
SYNOVUS FINANCIAL CORP | 11,796 | $43,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 77,097 | $279,000 | 0.00% |